AK
Arvind Kumar Gupta
About Arvind Kumar Gupta
Data last updated:
Arvind Kumar Gupta is a Director at Pharma Synth Formulations Limited (since 1993). The company operates in Pharma. Pharma Synth Formulations Limited reported revenue of ₹53.06 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pharma Synth Formulations Limited U74899DL1993PLC056231 | Director | 26 Nov 1993 | 1993 | ₹53.06 Cr (FY 2024) | Active |
Board colleagues of Arvind Kumar Gupta
| Name | DIN | Company | Designation |
|---|---|---|---|
| Phoolwati Jain | 00596821 | Pharma Synth Formulations Limited | Director |
| Ramesh Chand Jain | 00787319 | Pharma Synth Formulations Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arvind Kumar Gupta
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arvind Kumar Gupta
Arvind Kumar Gupta currently holds 1 directorship: Pharma Synth Formulations Limited (Director, since 26 Nov 1993, revenue ₹53.06 Cr (FY 2024)).
Arvind Kumar Gupta was first appointed on 26 Nov 1993 as Director at Pharma Synth Formulations Limited.
The current boards of Arvind Kumar Gupta's companies include Phoolwati Jain (Pharma Synth Formulations Limited), Ramesh Chand Jain (Pharma Synth Formulations Limited).